President Donald Trump said Friday that he intended to nominate Dr. Stephen Hahn, a top executive at The University of Texas MD Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration.
President Donald Trump said Friday that he intended to nominate Dr. Stephen Hahn, a top executive at The University of Texas MD Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration.
President Donald Trump was expected Friday to nominate Dr. Stephen Hahn, a top executive at The University of Texas MD Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration, according to a source familiar with the president’s decision.
The Trump administration said Wednesday it was taking steps to make it easier to import less expensive prescription drugs from other countries, particularly Canada. The move has long been supported by progressives, but has encountered fierce opposition from the pharmaceutical industry.
The Trump administration said Wednesday that it was taking steps to make it easier for less expensive prescription drugs to be imported from other countries, particularly Canada, a move that has long been supported by progressives but has encountered fierce opposition from the pharmaceutical industry.
Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday.
Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday.
Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday.Uganda New York Times world31 Jan 2019
EVANSTON, Ill. — It was minus 15 degrees here on Wednesday afternoon, near the epicenter of the polar vortex, and school had been canceled for much of the week.
Dr. John Mendelsohn, who led the prestigious University of Texas MD Anderson Cancer Center through an era of substantial growth, and who, as a scientist, helped pioneer a new type of cancer therapy, died Jan. 7 at his home in Houston. He was 82.
An advisory panel for the Food and Drug Administration split evenly Thursday over whether the agency should approve the first oral medication to treat Type 1 diabetes.